Search Results - "de Maat, M. P. M."

Refine Results
  1. 1
  2. 2

    Clinically relevant differences between assays for von Willebrand factor activity by Boender, J., Eikenboom, J., Bom, J. G., Meijer, K., Meris, J., Fijnvandraat, K., Cnossen, M. H., Laros‐van Gorkom, B. A. P., Heerde, W. L., Mauser‐Bunschoten, E. P., Maat, M. P. M., Leebeek, F. W. G.

    Published in Journal of thrombosis and haemostasis (01-12-2018)
    “…Essentials It is unclear whether there are differences between von Willebrand factor (VWF) activity assays. We compared the four most used VWF activity assays…”
    Get full text
    Journal Article
  3. 3

    Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma by Auwerda, Johannes J A, Yuana, Yuana, Osanto, Susanne, de Maat, Moniek P M, Sonneveld, Pieter, Bertina, Rogier M, Leebeek, Frank W G

    Published in Thrombosis and haemostasis (01-01-2011)
    “…Multiple myeloma (MM) is associated with an increased risk of venous thromboembolic (VTE) complications. Aim of this study was to measure…”
    Get more information
    Journal Article
  4. 4

    In vitro induction of NETosis: Comprehensive live imaging comparison and systematic review by Hoppenbrouwers, Tamara, Autar, Anouchska S A, Sultan, Andi R, Abraham, Tsion E, van Cappellen, Wiggert A, Houtsmuller, Adriaan B, van Wamel, Willem J B, van Beusekom, Heleen M M, van Neck, Johan W, de Maat, Moniek P M

    Published in PloS one (09-05-2017)
    “…Multiple inducers of in vitro Neutrophil Extracellular Trap (NET) formation (NETosis) have been described. Since there is much variation in study design and…”
    Get full text
    Journal Article
  5. 5

    Flow affects the structural and mechanical properties of the fibrin network in plasma clots by Eyisoylu, Hande, Hazekamp, Emma D., Cruts, Janneke, Koenderink, Gijsje H., de Maat, Moniek P. M.

    “…The fibrin network is one of the main components of thrombi. Altered fibrin network properties are known to influence the development and progression of…”
    Get full text
    Journal Article
  6. 6

    Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes by DEHGHAN, Abbas, KARDYS, Isabella, DE MAAT, Moniek P. M, UITTERLINDEN, Andre G, SIJBRANDS, Eric J. G, BOOTSMA, Aart H, STIJNEN, Theo, HOFMAN, Albert, SCHRAM, Miranda T, WITTEMAN, Jacqueline C. M

    Published in Diabetes (New York, N.Y.) (01-03-2007)
    “…Genetic Variation, C-Reactive Protein Levels, and Incidence of Diabetes Abbas Dehghan 1 , Isabella Kardys 1 , Moniek P.M. de Maat 2 , Andre G. Uitterlinden 1 3…”
    Get full text
    Journal Article
  7. 7

    Performance related factors are the main determinants of the von Willebrand factor response to exhaustive physical exercise by van Loon, Janine E, Sonneveld, Michelle A H, Praet, Stephan F E, de Maat, Moniek P M, Leebeek, Frank W G

    Published in PloS one (13-03-2014)
    “…Physical stress triggers the endothelium to release von Willebrand Factor (VWF) from the Weibel Palade bodies. Since VWF is a risk factor for arterial…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A by Stoof, Sara C M, Sanders, Yvonne V, Petrij, Fred, Cnossen, Marjon H, de Maat, Moniek P M, Leebeek, Frank W G, Kruip, Marieke J H A

    Published in Thrombosis and haemostasis (01-03-2013)
    “…Desmopressin causes two- to six-fold increase of factor VIII (FVIII) in mild or moderate haemophilia A patients. However, responses are variable and little is…”
    Get more information
    Journal Article
  10. 10

    Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients by van Loon, Janine E, Sanders, Yvonne V, de Wee, Eva M, Kruip, Marieke J H A, de Maat, Moniek P M, Leebeek, Frank W G

    Published in PloS one (06-07-2012)
    “…In type 1 von Willebrand Disease (VWD) patients, von Willebrand Factor (VWF) levels and bleeding symptoms are highly variable. Recently, the association…”
    Get full text
    Journal Article
  11. 11

    Fibrinogen concentration and its role in CVD risk in black South Africans--effect of urbanisation by Pieters, Marlien, de Maat, Moniek P M, Jerling, Johann C, Hoekstra, Tiny, Kruger, Annamarie

    Published in Thrombosis and haemostasis (01-09-2011)
    “…The aim of this study was to investigate correlates of fibrinogen concentration in black South Africans, as well as its association with cardiovascular disease…”
    Get more information
    Journal Article
  12. 12

    Biological variation in tPA-induced plasma clot lysis time by Talens, Simone, Malfliet, Joyce J M C, Rudež, Goran, Spronk, Henri M H, Janssen, Nicole A H, Meijer, Piet, Kluft, Cornelis, de Maat, Moniek P M, Rijken, Dingeman C

    Published in Thrombosis and haemostasis (01-10-2012)
    “…Hypofibrinolysis is a risk factor for venous and arterial thrombosis, and can be assessed by using a turbidimetric tPA-induced clot lysis time (CLT) assay…”
    Get more information
    Journal Article
  13. 13

    Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome by Bongers, Tamara N, Emonts, Marieke, de Maat, Moniek P M, de Groot, Ronald, Lisman, Ton, Hazelzet, Jan A, Leebeek, Frank W G

    Published in Thrombosis and haemostasis (01-06-2010)
    “…Multiple organ failure is a common feature of pediatric meningococcal sepsis and is associated with an imbalance of coagulation and fibrinolysis. This is…”
    Get more information
    Journal Article
  14. 14

    The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention by van Loon, Janine E, de Jaegere, Peter P T, Ulrichts, Hans, van Vliet, Huub H D M, de Maat, Moniek P M, de Groot, Philip G, Simoons, Maarten L, Leebeek, Frank W G

    Published in Thrombosis and haemostasis (01-07-2011)
    “…Compound ALX-0081 is a bivalent humanised Nanobody® that binds the A1-domain of von Willebrand factor (VWF) with high affinity. Consequently, it can block the…”
    Get more information
    Journal Article
  15. 15

    Automated Fiber Diameter and Porosity Measurements of Plasma Clots in Scanning Electron Microscopy Images by Daraei, Ali, Pieters, Marlien, Baker, Stephen R, de Lange-Loots, Zelda, Siniarski, Aleksander, Litvinov, Rustem I, Veen, Caroline S B, de Maat, Moniek P M, Weisel, John W, Ariëns, Robert A S, Guthold, Martin

    Published in Biomolecules (Basel, Switzerland) (18-10-2021)
    “…Scanning Electron Microscopy (SEM) is a powerful, high-resolution imaging technique widely used to analyze the structure of fibrin networks. Currently,…”
    Get full text
    Journal Article
  16. 16

    γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke by van den Herik, Evita G, Cheung, Elim Y L, de Lau, Lonneke M L, den Hertog, Heleen M, Leebeek, Frank W, Dippel, Diederik W J, Koudstaal, Peter J, de Maat, Moniek P M

    Published in Thrombosis and haemostasis (01-03-2011)
    “…Fibrinogen γ' (γ') is a natural isoform of fibrinogen, and alters the rate of formation and the properties of clots. It could therefore affect outcome after…”
    Get more information
    Journal Article
  17. 17

    The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor by Bouman, H J, van Werkum, J W, Rudez, G, Leebeek, F W G, Kruit, A, Hackeng, C M, Ten Berg, J M, de Maat, M P M, Ruven, H J T

    Published in Thrombosis and haemostasis (01-02-2010)
    “…Novel P2Y12 inhibitors are in development to overcome the occurrence of atherothrombotic events associated with poor responsiveness to the widely used P2Y12…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Fibrin structure and wound healing by LAURENS, N., KOOLWIJK, P., DE MAAT, M. P. M.

    Published in Journal of thrombosis and haemostasis (01-05-2006)
    “…Summary  Fibrinogen and fibrin play an important role in blood clotting, fibrinolysis, cellular and matrix interactions, inflammation, wound healing,…”
    Get full text
    Journal Article
  20. 20

    High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study by Libourel, Eduard J., Sonneveld, Pieter, van der Holt, Bronno, de Maat, Moniek P.M., Leebeek, Frank W.G.

    Published in Blood (08-07-2010)
    “…This prospective study evaluated the risk of arterial thrombosis in 195 consecutive patients aged 18 to 65 years with newly diagnosed multiple myeloma (MM)…”
    Get full text
    Journal Article